Balgrist Universitaets   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Zurich Switzerland (1912)

Organization Overview

First Clinical Trial
2001
NCT00020566
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Balgrist Universitätsklinik | Balgrist University Hospital | Radiology University Hospital Balgrist | susanne becker | University Hospital Balgrist

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Infections (Phase 3)

Nausea (Phase 3)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Pain, Postoperative (Phase 3)

Postoperative Nausea and Vomiting (Phase 3)

Sarcoma (Phase 3)

Urinary Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 23